Skip to content

Pomalidomide

Pomalidomide (Pomalyst) is a capsule used to treat multiple myeloma. The single-brand catalogue contains one product, with the medicine originating from Bristol-Myers Squibb Pharmaceuticals Limited.

Pomalyst

Multiple Myeloma

4mg

Pomalidomide capsules for multiple myeloma. This is a newer generation of a drug class that works with the immune system to target myeloma cells.

From$63.90/ capsuleView

Key points

  • Pomalidomide is an immunomodulator that acts on the immune system to treat multiple myeloma.
  • The sole product is Pomalyst 4 mg capsule, originating from Bristol-Myers Squibb.
  • Pomalidomide is the active ingredient; Pomalyst is the brand name under which it is listed.

What Pomalidomide is used for

Pomalidomide is used in the treatment of multiple myeloma, a cancer that affects plasma cells in the bone marrow. The medicine pomalidomide falls under Oncology Support, and the capsule form means it is taken by mouth as a solid dose.

Further reading